Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel
ABSTRACTCOVID-19 vaccination is effective at reducing SARS-CoV-2 complications, but uptake has been low. Our objective in this study was to compare the importance of factors reported to influence the decision to receive a bivalent COVID-19 booster vaccine among health care personnel (HCP) tested for...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2023.2284471 |
_version_ | 1827380926172102656 |
---|---|
author | Nicholas M. Mohr Ian D. Plumb Eliezer Santos León Karisa K. Harland Anusha Krishnadasan Utsav Nandi Karin F. Hoth Howard A. Smithline David A. Talan |
author_facet | Nicholas M. Mohr Ian D. Plumb Eliezer Santos León Karisa K. Harland Anusha Krishnadasan Utsav Nandi Karin F. Hoth Howard A. Smithline David A. Talan |
author_sort | Nicholas M. Mohr |
collection | DOAJ |
description | ABSTRACTCOVID-19 vaccination is effective at reducing SARS-CoV-2 complications, but uptake has been low. Our objective in this study was to compare the importance of factors reported to influence the decision to receive a bivalent COVID-19 booster vaccine among health care personnel (HCP) tested for SARS-CoV-2 between October 2022 and April 2023 in a 20-hospital vaccine effectiveness study in the United States (n = 1656). Compared with those who had not received the booster, the factors most likely to be reported to be important were concerns about contracting COVID-19 (84.0% of those who had received the bivalent booster vs. 47.5% of those who had not, difference 36.6% points (PP), 95% confidence interval [CI] 32.1 to 41.1%), spreading infection to family members (89.2% vs. 62.8%, difference 26.3 PP, 95% CI 22.3 to 30.4%), and spreading infection to colleagues at work (85.5% vs. 59.4%, difference 26.1 PP, 95% CI 21.7 to 30.5%). HCP who had received the booster more frequently cited the primary literature (61.7% vs. 31.8%, difference 29.9 PP, 95% CI 24.6 to 35.2%) and employer recommendations (48.3% vs. 29.8%, difference 18.5 PP, 95% CI 13.2 to 23.9%) as influencing their decision. This analysis provides insight into factors for targeting future vaccine messaging. |
first_indexed | 2024-03-08T13:46:41Z |
format | Article |
id | doaj.art-c17cfa3a89044f24afd9cf4acbd7e55b |
institution | Directory Open Access Journal |
issn | 2164-5515 2164-554X |
language | English |
last_indexed | 2024-03-08T13:46:41Z |
publishDate | 2023-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Human Vaccines & Immunotherapeutics |
spelling | doaj.art-c17cfa3a89044f24afd9cf4acbd7e55b2024-01-16T09:14:10ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2023-12-0119310.1080/21645515.2023.2284471Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnelNicholas M. Mohr0Ian D. Plumb1Eliezer Santos León2Karisa K. Harland3Anusha Krishnadasan4Utsav Nandi5Karin F. Hoth6Howard A. Smithline7David A. Talan8Department of Emergency Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USACOVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GeorgiaDepartment of Emergency Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USADepartment of Emergency Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USAOlive View-UCLA Education and Research Institute, Olive View-UCLA Medical Center, Los Angeles, CA, USADepartment of Emergency Medicine, University of Mississippi Medical Center, Jackson, MS, USADepartment of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USADepartment of Emergency Medicine, University of Massachusetts Chan Medical School, Springfield, MA, USADepartment of Emergency Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USAABSTRACTCOVID-19 vaccination is effective at reducing SARS-CoV-2 complications, but uptake has been low. Our objective in this study was to compare the importance of factors reported to influence the decision to receive a bivalent COVID-19 booster vaccine among health care personnel (HCP) tested for SARS-CoV-2 between October 2022 and April 2023 in a 20-hospital vaccine effectiveness study in the United States (n = 1656). Compared with those who had not received the booster, the factors most likely to be reported to be important were concerns about contracting COVID-19 (84.0% of those who had received the bivalent booster vs. 47.5% of those who had not, difference 36.6% points (PP), 95% confidence interval [CI] 32.1 to 41.1%), spreading infection to family members (89.2% vs. 62.8%, difference 26.3 PP, 95% CI 22.3 to 30.4%), and spreading infection to colleagues at work (85.5% vs. 59.4%, difference 26.1 PP, 95% CI 21.7 to 30.5%). HCP who had received the booster more frequently cited the primary literature (61.7% vs. 31.8%, difference 29.9 PP, 95% CI 24.6 to 35.2%) and employer recommendations (48.3% vs. 29.8%, difference 18.5 PP, 95% CI 13.2 to 23.9%) as influencing their decision. This analysis provides insight into factors for targeting future vaccine messaging.https://www.tandfonline.com/doi/10.1080/21645515.2023.2284471COVID-19 vaccinesvaccination hesitancyhealth personnelpublic healthoccupational health |
spellingShingle | Nicholas M. Mohr Ian D. Plumb Eliezer Santos León Karisa K. Harland Anusha Krishnadasan Utsav Nandi Karin F. Hoth Howard A. Smithline David A. Talan Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel Human Vaccines & Immunotherapeutics COVID-19 vaccines vaccination hesitancy health personnel public health occupational health |
title | Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel |
title_full | Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel |
title_fullStr | Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel |
title_full_unstemmed | Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel |
title_short | Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel |
title_sort | factors associated with the decision to receive bivalent covid 19 booster vaccination among health care personnel |
topic | COVID-19 vaccines vaccination hesitancy health personnel public health occupational health |
url | https://www.tandfonline.com/doi/10.1080/21645515.2023.2284471 |
work_keys_str_mv | AT nicholasmmohr factorsassociatedwiththedecisiontoreceivebivalentcovid19boostervaccinationamonghealthcarepersonnel AT iandplumb factorsassociatedwiththedecisiontoreceivebivalentcovid19boostervaccinationamonghealthcarepersonnel AT eliezersantosleon factorsassociatedwiththedecisiontoreceivebivalentcovid19boostervaccinationamonghealthcarepersonnel AT karisakharland factorsassociatedwiththedecisiontoreceivebivalentcovid19boostervaccinationamonghealthcarepersonnel AT anushakrishnadasan factorsassociatedwiththedecisiontoreceivebivalentcovid19boostervaccinationamonghealthcarepersonnel AT utsavnandi factorsassociatedwiththedecisiontoreceivebivalentcovid19boostervaccinationamonghealthcarepersonnel AT karinfhoth factorsassociatedwiththedecisiontoreceivebivalentcovid19boostervaccinationamonghealthcarepersonnel AT howardasmithline factorsassociatedwiththedecisiontoreceivebivalentcovid19boostervaccinationamonghealthcarepersonnel AT davidatalan factorsassociatedwiththedecisiontoreceivebivalentcovid19boostervaccinationamonghealthcarepersonnel |